Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response

PLoS Neglected Tropical Diseases

Volumn 8, Issue 4, 2014, Pages

  Liu, Xiang ^a   Foo, Geraldine ^b   Lim, Wan Peng ^c   Ravikumar, Sharada ^a   Sim, Siew Hoon ^d   Win, Mar Soe ^a   Goh, Jessamine Geraldine ^a   Lim, Joan Hui Juan ^a   Ng, Ying Hui ^b   Fisher, Dale ^a,e   Khoo, Chin Meng ^a,e   Tan, Gladys ^d   Chai, Louis Yi Ann ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d DSO NATIONAL LABORATORIES   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL ANTIGEN; BETA ACTIN; CD14 ANTIGEN; CEFTAZIDIME; COTRIMOXAZOLE; DOXYCYCLINE; GAMMA INTERFERON; GLIBENCLAMIDE; HEMOGLOBIN A1C; IMIPENEM; INSULIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 1BETA; MEROPENEM; MESSENGER RNA; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; SULFONYLUREA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CELL STIMULATION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HYPOTENSION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; MIDDLE AGED; MORTALITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA TRANSCRIPTION; SEPTICEMIA; WESTERN BLOTTING;

ASIA, SOUTHEASTERN; AUSTRALIA; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LENGTH OF STAY; MALE; MELIOIDOSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; SULFONYLUREA COMPOUNDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84901280798     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002795     Document Type: Article

References (16)

1. Currie BJ, Jacups SP, (2003) Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9: 1538-1542.
2. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, et al. (2000) Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31: 981-986.
3. Currie BJ, Dance DA, Cheng AC, (2008) The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg 102 Suppl 1: S1-4.
4. Tan KS, Lee KO, Low KC, Gamage AM, Liu Y, et al. (2012) Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122: 2289-2300.
5. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, et al. (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187: 61-70.
6. Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, et al. (2010) Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther 334: 206-213.
7. Wiersinga WJ, van der Poll T, (2009) Immunity to Burkholderia pseudomallei. Curr Opin Infect Dis 22: 102-108.
8. Panomket P, (2011) Immune response to Burkholderia pseudomallei. J Med Assoc Thai 94: 1410-1417.
9. Wiersinga WJ, van't Veer C, van den Pangaart PS, Dondorp AM, Day NP, et al. (2009) Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit Care Med 37: 569-576.
10. Koh GC, Maude RR, Schreiber MF, Limmathurotsakul D, Wiersinga WJ, et al. (2011) Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 52: 717-725.
11. Cheng AC, (2009) Melioidosis: advances in diagnosis and treatment. Curr Opin Infect Dis 23: 554-559.
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: 580-637.
13. Chai LY, Kullberg BJ, Vonk AG, Warris A, Cambi A, et al. (2009) Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 77: 2184-2192.
14. Hubbard LL, Moore BB, (2010) IRAK-M regulation and function in host defense and immune homeostasis. Infect Dis Rep 2: 1.
15. Picard C, Casanova JL, Puel A, (2011) Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev 24: 490-497.
16. Wiersinga WJ, Currie BJ, Peacock SJ, (2012) Melioidosis. N Engl J Med 367: 1035-1044.